Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro. (Q37030376)
Jump to navigation
Jump to search
scientific article published on 09 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro. |
scientific article published on 09 January 2012 |
Statements
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro (English)
Yoon Woo Koh
Manisha H Shah
Kitty Agarwal
Samantha K McCarty
Victoria J Brendel
Chaojie Wang
David Jarjoura
Motoyasu Saji
Matthew D Ringel
1 reference